NIH-funded research NIH-funded research

Advanced nanoparticle tracking technology for biomedical research

Official title: ZetaView x30 QUATT Multi-Fluorescence Nanoparticle Tracking Analyzer

Funded at University of California, San Diego · NIH-10854023 · Data updated 2026-11-12

This study is all about getting a new high-tech tool that helps scientists better understand tiny particles in our bodies that can affect health, and it will be available for researchers at UC San Diego and nearby places to work together on important medical discoveries.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2025
Funding year2024
Award (this year)$180,430
NIH project number1S10OD036412-01
Project IDNIH-10854023 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research include patients with conditions related to cancer, diabetes, and other diseases where extracellular vesicles play a critical role.

Less likely to help

Patients with conditions unrelated to extracellular vesicles or those not participating in research activities at UC San Diego may not receive direct benefits from this research.

What this research studies

This research focuses on acquiring a state-of-the-art ZetaView® x30 QUATT Multi-Fluorescence Nanoparticle Tracking Analyzer, which will enhance the study of extracellular vesicles and bio-nanoparticles. The analyzer allows researchers to measure various properties of nanoparticles, including size, concentration, and fluorescence, with the unique ability to assess the colocalization of fluorescence signals. This capability is crucial for accurately characterizing different subpopulations of extracellular vesicles, which can lead to significant advancements in understanding various diseases. The instrument will be accessible to researchers at UC San Diego and nearby institutions, promoting collaboration and innovation in multiple biomedical fields.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic and therapeutic strategies for diseases such as cancer and diabetes by enhancing our understanding of extracellular vesicles.

How similar studies have gone: Other research has successfully utilized advanced nanoparticle tracking technologies, indicating a promising potential for this approach.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Wang, Shizhen Emily — University of California, San Diego
  • Study coordinator: Wang, Shizhen Emily

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.